Cardiologic Manifestations in Omicron-Type Versus Wild-Type COVID-19: A Systematic Echocardiographic Study. 1/25/2023. Ghantous E. J Am Heart Assoc. Study designed to compare echocardiographic findings in patients hospitalized with COVID-19 between early Wild-Type...
Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease. 11/15/22. Hoertel N. JAMA Netw Open. Nirmatrelvir-ritonavir (Paxlovid) reduces COVID-related morbidity and mortality....
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo. 12/7/22. Torchia JA. Science Advances. These investigators report the development of recombinant soluble forms of the cell surface...
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. 12/25/2022. Butler CC. Lancet. Reviews prior to this study...
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. 12/19/2022. Cao Y. Nature. Immune imprinting occurs when exposure to an original viral strain prevents our bodies from producing sufficient neutralizing antibodies (NAb) against diverse...
